Back to TCRX
LETKO, BROSSEAU & ASSOCIATES INC → TCRX
LETKO, BROSSEAU & ASSOCIATES INC TCRX Position History
TScan Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$30K
Q3 2026
Peak value
$174K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $174K |
| Q4 2025 | $96K |
| Q1 2026 | $97K |
| Q2 2026 | $94K |
| Q3 2026 | $30K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $30K | 95.9K | — | — |
| Q2 2026 | $94K | 95.9K | — | — |
| Q1 2026 | $97K | 95.9K | — | — |
| Q4 2025 | $96K | 95.9K | — | — |
| Q3 2025 | $174K | 95.9K | — | — |
Other funds holding TCRX
$630M
$630M
$617.5M
$198.1M
$10.9M